ANALYTICAL METHOD DEVELOPMENT

Expert Analytical Solutions For Your Product

At Altruist, our analytical development team specializes in method development, transfer and phase-appropriate validation to meet CMC requirements to assess the physiochemical and biochemical characteristics of each product, as well as comprehensive characterization analysis including primary and higher-order structures, and immunological properties.

Laboratory technician analyzing samples with specialized equipment in a modern research facility.

Method Development & Optimization

With up-to-date knowledge of regulatory requirements, our expert staff can provide and execute customized method development plans to meet your timelines.

Method Qualification & Validation

For DS/DP release assays, we provide analytical method qualification and validation through product-specific, process-related, and microbiological methods – all following ICH guidelines.

Method Transfer

We provide method transfer services to support characterization methods as well as GMP clinical/commercial release and stability testing.

Method Lifecycle Management

Our experts can provide continuous method evaluation throughout your product’s lifecycle.

Analytical Testing & Characterization Capabilities

Our capabilities and cutting-edge analytical instrumentation cover the requirements for comprehensive cGMP quality control testing. Among several identity methods, the multi-attribute method (MAM) is used to determine the amino acid sequence and identify post-translational modifications. 

From characterization to stability testing, we offer a range of in-house analytical services tailored to biologics development.  

  • Method transfer 
  • Development of customized methods, including bioassays 
  • Biological, physiochemical, bioactivity, biosafety and characterization testing 
  • Phase-appropriate validation 
  • In-process and release testing 
  • cGMP stability studies 
  • Clinical in-use studies Comparability testing for both clinical and post-approval process changes 
  • Similarity study for biosimilar development 
  • Characterization capabilities for IND/IMPD or BLA/MAA filings 
  • Standardized sample management workflow Fully automated and high throughput sample preparation platform (Tecan) and testing equipment (LabChip) 
  • Quality by design (QbD)-guided product critical quality attribute (CQA) assessment

Analytical Method

  • Purity: CE-SDS, SEC, icIEF,CEX 
  • General/Safety/Appearance: Compendial Testing to USP, EP, JP, etc 
  • Quantity: Protein concentration 
  • Potency: Binding ELISA, bioassay 
  • Identity: Peptide mapping, icIEF, IEX and FFE 
  • Impurity: Residual DNA, HCP, Protein A

Extended Characterization

  • Primary Structure: Intact Molecular Weight, Reduced Molecular Weight, Identification of CDR region, Amino acid sequence coverage, Disulfide bond analysis 
  • Higher-Order Structure: Free sulfhydryl group analysis, CD, FT-IR, NMR, Thermal stability 
  • PTM: Oxidation sites and proportions, Deamidation sites and proportions, N-glycosylation site, N-glycosylation profiling 
  • Purity: Aggregates and fragments 
  • Charge variants: Acidic variants, basic variants 
  • Glycosylation Heterogeneity: Site, Occupancy, Glycan profiling, -Potency and Immunology properties: Binding Affinity, Cell-based biological activity, ADCC/CDC/ADCP, SPR, Affinity with FcRn, Affinity with the FcγRⅠ, FcγRⅢa, Affinity with C1q

CONTACT US

Ready to Take The Next Step?

From process development to clinical and commercial cGMP release testing, discover how we can support your analytical needs with quality CMC-focused services.